JHS Svendgaard LaboratoriesNSE:JHS +0.66%53 Days Payable is 65.83 as of Mar. 2026, which is 26% below its 10-year median of 89.50. GuruFocus rates NSE:JHS with a GF Score™ of 53/100 and a GF Value™ of ₹22.11 (Possible Value Trap). The stock has 3 warning signs investors should review. Among 1,882 Consumer Packaged Goods companies, JHS Svendgaard Laboratories ranks better than 77.21% on this metric.
The historical rank and industry rank for JHS Svendgaard Laboratories's Days Payable or its related term are showing as below:
NSE:JHS'
s Days Payable Range Over the Past 10 Years
Min: 69.18 Med: 89.5 Max: 129.06
Current: 82.04
During the past 13 years, JHS Svendgaard Laboratories's highest Days Payable was 129.06. The lowest was 69.18. And the median was 89.50.
NSE:JHS's Days Payable is ranked better than 77.21% of 1882
companies
in the Consumer Packaged Goods industry
Industry Median: 44.145
vs NSE:JHS: 82.04
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Household & Personal Products subindustry, JHS Svendgaard Laboratories's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
JHS Svendgaard Laboratories Days Payable vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, JHS Svendgaard Laboratories's Days Payable distribution charts can be found below:
* The bar in red indicates where JHS Svendgaard Laboratories's Days Payable falls into.
JHS Svendgaard Laboratories Days Payable Calculation
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
JHS Svendgaard Laboratories (NSE:JHS) has a Days Payable of 65.83 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on JHS Svendgaard Laboratories and its competitors. This is 26% below median its historical median of 89.50. Over the past decade, JHS Svendgaard Laboratories' Days Payable has ranged from 69.18 to 129.06. According to the industry distribution chart, JHS Svendgaard Laboratories ranks #429 out of 1882 companies in the Consumer Packaged Goods industry, placing it in the top 22.8%.
Is JHS Svendgaard Laboratories' Days Payable too high?
JHS Svendgaard Laboratories' current Days Payable of 65.83 is 26% below median its 10-year median of 89.50. Over the past 10 years, this metric has ranged from a low of 69.18 to a high of 129.06. The Consumer Packaged Goods industry median Days Payable is 44.15. JHS Svendgaard Laboratories' value of 65.83 is 49.1% above this industry median. Based on the distribution chart, JHS Svendgaard Laboratories ranks #429 out of 1882 companies in the Consumer Packaged Goods industry, which is in the top quartile — a strong position relative to peers. Overall, JHS Svendgaard Laboratories has a GF Score™ of 53/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does JHS Svendgaard Laboratories' Days Payable compare to PG and CL?
According to the Consumer Packaged Goods industry distribution chart, JHS Svendgaard Laboratories ranks #429 out of 1882 companies for Days Payable. This places JHS Svendgaard Laboratories in the top 23% of its industry — outperforming the majority of peers. The industry median Days Payable is 44.15. JHS Svendgaard Laboratories' value of 65.83 is 49.1% above this benchmark. Historically, JHS Svendgaard Laboratories' own Days Payable has ranged from 69.18 to 129.06 over the past decade. While the company's 10-year median is 89.50 vs. the industry median of 44.15, JHS Svendgaard Laboratories has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Consumer Packaged Goods company?
The median Days Payable among Consumer Packaged Goods companies is 44.15, based on 1,882 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. JHS Svendgaard Laboratories's current Days Payable of 65.83 is 49.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on JHS Svendgaard Laboratories and its competitors. For the Consumer Packaged Goods industry, the median Days Payable is 44.15 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. JHS Svendgaard Laboratories's current Days Payable is 65.83, which is 26% below median its own 10-year median of 89.50. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is JHS Svendgaard Laboratories stock overvalued right now?
Based on GuruFocus' analysis, JHS Svendgaard Laboratories (NSE:JHS) is currently considered Possible Value Trap. The stock's GF Value™ is ₹22.11, compared to a current price of ₹7.64 — trading 65.4% below its estimated fair value. The current Days Payable is 65.83, which is 26% below median its 10-year median of 89.50 and 49.1% above the Consumer Packaged Goods industry median of 44.15. JHS Svendgaard Laboratories' overall GF Score™ is 53/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For JHS Svendgaard Laboratories (NSE:JHS), the current Days Payable is 65.83 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is JHS Svendgaard Laboratories (NSE:JHS) Overvalued in 2026?
Based on GuruFocus' analysis, JHS Svendgaard Laboratories stock appears to be undervalued.
The current stock price of ₹7.64 is trading 65.4% below its estimated GF Value™ of ₹22.11.
GuruFocus considers JHS Svendgaard Laboratories to be Possible Value Trap.
Key valuation signals for NSE:JHS:
Days Payable: 65.83 (26% below median its 10-year median of 89.50)
GF Value™: ₹22.11 vs. price of ₹7.64 (65.4% below fair value)
Industry Position: 49.1% above the Consumer Packaged Goods median (#429 of 1882)
No single metric tells the full story. See the NSE:JHS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
JHS Svendgaard Laboratories Ltd is engaged in manufacturing a range of oral and dental products for elite national and international brands. The main portfolio of the Group is to carry out manufacturing and exporting of oral care and hygiene products, including toothbrushes, toothpastes, mouthwash, sanizers, and job work of detergent powder. The Company is into manufacturing toothpaste, toothbrushes, Talcum, and Others. The toothbrushes segment generates the key revenue.
53GF Score
Get the complete analysis for NSE:JHS
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:JHS has been successfully added to your 
